Lv4
600 积分 2021-07-07 加入
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
3个月前
已完结
Repeating measurements by transient elastography in non‐alcoholic fatty liver disease patients with high liver stiffness
5个月前
已完结
1079-P: FIB-4 Forward—Enhancing MASLD Screening in Patients with Type 2 Diabetes Using an EHR-Based Tool
5个月前
已关闭
FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
5个月前
已完结
P04 Pilot study to identify undiagnosed NAFLD with moderate to advanced fibrosis in a primary care population
5个月前
已关闭
Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’ pathway for fibrosis risk assessment in primary care
5个月前
已完结
Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples
5个月前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
7个月前
已完结
皖公网安备34019202002308
